Peter Greenleaf Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Peter Greenleaf.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Peter Greenleaf. Peter Greenleaf is a Senior VP, Sales & Marketing in MEDIMMUNE INC /DE ($MEDI) and a SVP, Sales & Marketing in MEDIMMUNE INC /DE ($MEDI) and a SVP, Sales and Marketing in MEDIMMUNE INC /DE ($MEDI) and a Director in ANTARES PHARMA, INC. ($ATRS) and a Director in BIODELIVERY SCIENCES INTERNATIONAL INC ($BDSI) and a Director in Mast Therapeutics, Inc. ($MSTX) and a CEO in Sucampo Pharmaceuticals, Inc. ($SCMP) and an Chief Executive Officer in Sucampo Pharmaceuticals, Inc. ($SCMP) and a Director in EYEGATE PHARMACEUTICALS INC ($EYEG) and a Director in Mirna Therapeutics, Inc. ($MIRN) and a in Cerecor Inc. ($CERC) and an Chief Executive Officer in Cerecor Inc. ($CERC) and a Director in Cerecor Inc. ($CERC) and an Chief Executive Officer in Aurinia Pharmaceuticals Inc. ($AUPH).

Address: ONE MEDIMMUNE WAY GAITHERSBURG 20878 MD

Companies in which Peter Greenleaf is an Insider

ANTARES PHARMA, INC.

Trading Symbol: ATRS
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Peter Greenleaf: Director
Holdings: 54,193 shares
Current Value: $119,225
Latest Transaction: Jun 15 2020
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Aurinia Pharmaceuticals Inc.

Trading Symbol: AUPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Greenleaf: Chief Executive Officer
Holdings: 10,461 shares
Latest Transaction: May 12 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

BIODELIVERY SCIENCES INTERNATIONAL INC

Trading Symbol: BDSI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Greenleaf: Director
Holdings: 59,788 shares
Current Value: $116,587
Latest Transaction: Aug 11 2020
$BDSI Market Capitalization: $106.88M
$BDSI Previous Close: $1.95

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Cerecor Inc.

Trading Symbol: CERC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Greenleaf: Director, Chief Executive Officer
Holdings: 112,500 shares
Current Value: $93,375
Latest Transaction: Oct 03 2019
$CERC Market Capitalization: $7.38M
$CERC Previous Close: $0.83

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

EYEGATE PHARMACEUTICALS INC

Trading Symbol: EYEG
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Greenleaf: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 05 2019
$EYEG Market Capitalization: $15.24M
$EYEG Previous Close: $1.58

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

MEDIMMUNE INC /DE

Trading Symbol: MEDI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Peter Greenleaf: SVP, Sales and Marketing, Senior VP, Sales & Marketing, SVP, Sales & Marketing
Holdings: 0 shares
Latest Transaction: Jun 19 2007

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Savara Inc

Trading Symbol: SVRA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Greenleaf: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 23 2017
$SVRA Market Capitalization: $32.99M
$SVRA Previous Close: $0.14

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Sucampo Pharmaceuticals, Inc.

Trading Symbol: SCMP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Greenleaf: CEO, Chief Executive Officer
Holdings: 4,792 shares
Current Value: $54,389
Latest Transaction: Jan 04 2018
$SCMP Market Capitalization: $496.69M
$SCMP Previous Close: $11.35

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SYNLOGIC, INC.

Trading Symbol: SYBX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Greenleaf: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 06 2016
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Peter Greenleaf

Sentiment: All, ATRS, AUPH, BDSI, CERC, EYEG, MEDI, SVRA, SCMP, SYBX

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 12 2021AUPHAurinia Pharmaceut ...Greenleaf PeterChief Executive Off ...BuyP11.112,99233,24113,45310.5 K to 13.5 K (+28.60 %)
May 12 2021AUPHAurinia Pharmaceut ...Greenleaf PeterChief Executive Off ...BuyP10.152,13321,65010,4618.3 K to 10.5 K (+25.61 %)
Aug 11 2020BDSIBIODELIVERY SCIENC ...Greenleaf PeterDirectorOption ExerciseM0.0035,000052,500
Aug 11 2020BDSIBIODELIVERY SCIENC ...Greenleaf PeterDirectorBuyM0.0035,000059,78824.8 K to 59.8 K (+141.20 %)
Jun 15 2020ATRSANTARES PHARMA, IN ...Greenleaf PeterDirectorOption ExerciseA2.7358,246159,01258,246
Jun 15 2020ATRSANTARES PHARMA, IN ...Greenleaf PeterDirectorGrantA2.7330,22082,50154,19324 K to 54.2 K (+126.06 %)
Oct 03 2019CERCCerecor Inc.Greenleaf PeterDirectorOption ExerciseA2.9325,00073,25025,000

View all Peter Greenleaf insider transactions.

What Happens When a Company Gets Delisted?

When listed on a major exchange, such as the NYSE or Nasdaq, the companies and their stock have to meet several listing requirements on stock price, trading volume, capitalization, disclosure of material information or financial reporting. More ...

What Do the Transaction Codes Mean?

Each transaction listed on the Form 4 filing must be marked with a transaction code. Here is a list and description of transaction codes as used and categorized by the SEC. More ...

What Is Illegal Insider Trading?

Illegal Insider trading occurs when a trade has been influenced by the possession of "material" and "non-public" information about the security. Because such information is not available to other investors, a person using it is trying to gain an unfair advantage over others. More ...

Contact us | Follow us on Twitter